This Dallas Firm Won a $1.6 Billion Whistleblower Case Against Johnson & Johnson - D Magazine
A federal judge ruled last month in favor of whistleblowers who reported to the government that Johnson & Johnson subsidiary Janssen (now called J&J Innovative Medicine) illegally marketed...
Read more